Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$25.97
-2.0%		$24.12
$15.73
▼
$30.00
$13.70B0.67.52 million shs4.50 million shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$116.33
-2.4%		$118.91
$100.85
▼
$212.00
$3.93B1.3701,633 shs402,567 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$321.51
-0.5%		$320.62
$221.26
▼
$362.41
$12.72B0.7261,616 shs476,703 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$29.14
-0.6%		$30.24
$28.56
▼
$38.79
$12.30B0.551.39 million shs1.11 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-2.14%-1.51%+6.47%+38.29%+5.69%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-2.37%-9.10%-0.89%+2.13%-31.49%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.57%-0.83%+0.47%+0.96%+20.01%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
-0.63%+0.26%-10.45%-1.96%-21.84%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Baxter International Inc. stock logo
BAX
Baxter International
$25.97
-2.0%		$24.12
$15.73
▼
$30.00
$13.70B0.67.52 million shs4.50 million shs
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$116.33
-2.4%		$118.91
$100.85
▼
$212.00
$3.93B1.3701,633 shs402,567 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$321.51
-0.5%		$320.62
$221.26
▼
$362.41
$12.72B0.7261,616 shs476,703 shs
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$29.14
-0.6%		$30.24
$28.56
▼
$38.79
$12.30B0.551.39 million shs1.11 million shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Baxter International Inc. stock logo
BAX
Baxter International
-2.14%-1.51%+6.47%+38.29%+5.69%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-2.37%-9.10%-0.89%+2.13%-31.49%
Penumbra, Inc. stock logo
PEN
Penumbra
-0.57%-0.83%+0.47%+0.96%+20.01%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
-0.63%+0.26%-10.45%-1.96%-21.84%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Baxter International Inc. stock logo
BAX
Baxter International
2.00
Hold$22.45-13.55% Downside
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2.94
Moderate Buy$179.9354.67% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.18
Hold$367.0714.17% Upside
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
2.00
Hold$30.936.14% Upside

Current Analyst Ratings Breakdown

Latest IRTC, BAX, PEN, and SNN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/24/2026
Penumbra, Inc. stock logo
PEN
Penumbra
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/18/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$180.00 ➝ $168.00
8/11/2026
Baxter International Inc. stock logo
BAX
Baxter International
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/10/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Truist Financial Corporation logo
Truist Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$160.00 ➝ $168.00
8/7/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetBuy$255.00 ➝ $192.00
8/7/2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$180.00 ➝ $168.00
8/7/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/6/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight ➝ Neutral
8/5/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/5/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
Barclays PLC logo
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeEqual Weight ➝ Underweight
7/31/2026
Baxter International Inc. stock logo
BAX
Baxter International
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D-) ➝ Sell (D)
(Data available from 8/28/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Baxter International Inc. stock logo
BAX
Baxter International
$11.47B1.17$5.57 per share4.66$11.95 per share2.17
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
$747.14M5.13N/AN/A$5.64 per share20.63
Penumbra, Inc. stock logo
PEN
Penumbra
$1.40B9.02$4.28 per share75.15$38.86 per share8.27
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$6.16B1.98$3.41 per share8.54$12.34 per share2.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Baxter International Inc. stock logo
BAX
Baxter International
-$957M-$2.07N/A12.924.01-9.27%16.57%5.24%10/29/2026 (Estimated)
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$44.55M-$0.43N/A80.23N/A-1.69%10.11%1.53%10/29/2026 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$177.69M$4.0778.9951.772.0010.67%10.50%8.17%11/4/2026 (Estimated)
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$625MN/AN/A12.241.09N/AN/AN/AN/A

Latest IRTC, BAX, PEN, and SNN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
-$0.04$0.58+$0.62-$0.01$219.30 million$224.17 million
7/30/2026Q2 2026
Baxter International Inc. stock logo
BAX
Baxter International
$0.3665$0.56+$0.1935$0.24$2.80 billion$2.96 billion
7/30/2026Q2 2026
Penumbra, Inc. stock logo
PEN
Penumbra
$1.16$0.88-$0.28$0.88$389.64 million$390.05 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Baxter International Inc. stock logo
BAX
Baxter International
$0.040.15%-11.54%N/A N/A
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.933.19%N/AN/AN/A

Latest IRTC, BAX, PEN, and SNN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/4/2026
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
$0.31202.05%10/2/202610/2/202611/6/2026
7/29/2026
Baxter International Inc. stock logo
BAX
Baxter International
quarterly$0.010.15%8/28/20268/28/202610/1/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Baxter International Inc. stock logo
BAX
Baxter International
1.39
1.95
1.32
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
3.50
3.86
3.74
Penumbra, Inc. stock logo
PEN
Penumbra
0.01
5.75
3.86
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
0.62
2.14
1.11

Institutional Ownership

CompanyInstitutional Ownership
Baxter International Inc. stock logo
BAX
Baxter International
90.19%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
N/A
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
25.64%

Insider Ownership

CompanyInsider Ownership
Baxter International Inc. stock logo
BAX
Baxter International
0.17%
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
0.98%
Penumbra, Inc. stock logo
PEN
Penumbra
2.90%
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
1.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Baxter International Inc. stock logo
BAX
Baxter International
37,500517.00 million516.12 millionOptionable
iRhythm Technologies stock logo
IRTC
iRhythm Technologies
2,40032.96 million32.64 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,70039.39 million38.25 millionOptionable
Smith & Nephew SNATS, Inc. stock logo
SNN
Smith & Nephew SNATS
16,988419.93 million415.73 millionOptionable

Recent News About These Companies

Hsbc Holdings PLC Purchases New Stake in Smith & Nephew SNATS, Inc. $SNN
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-hsbc-holdings-plc-purchases-new-stake-in-smith-nephew-snats-inc-snn-2026-08-28/
Smith & Nephew SNATS, Inc. (NYSE:SNN) Given Average Rating of "Hold" by Brokerages
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-smith-nephew-snats-inc-nyse-snn-given-average-rating-of-hold-by-brokerages-2026-08-28/
Caisse de depot et placement du Quebec Takes Position in Smith & Nephew SNATS, Inc. $SNN
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-caisse-de-depot-et-placement-du-quebec-takes-position-in-smith-nephew-snats-inc-snn-2026-08-28/
555,999 Shares in Smith & Nephew SNATS, Inc. $SNN Bought by The Manufacturers Life Insurance Company
August 27 at 5:12 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-555999-shares-in-smith-nephew-snats-inc-snn-bought-by-the-manufacturers-life-insurance-company-2026-08-27/
PDT Partners LLC Takes $4.25 Million Position in Smith & Nephew SNATS, Inc. $SNN
August 26 at 5:59 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-pdt-partners-llc-takes-425-million-position-in-smith-nephew-snats-inc-snn-2026-08-26/
UBS cuts Smith & Nephew target on competitive threats to three franchises
August 25 at 11:22 AM  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1097552?snapi
Commerce Bank Makes New Investment in Smith & Nephew SNATS, Inc. $SNN
August 25 at 3:52 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-commerce-bank-makes-new-investment-in-smith-nephew-snats-inc-snn-2026-08-25/
BlackRock Inc. Invests $505.32 Million in Smith & Nephew SNATS, Inc. $SNN
August 25 at 3:35 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-blackrock-inc-invests-50532-million-in-smith-nephew-snats-inc-snn-2026-08-25/
Bank of New York Mellon Corp Invests $89.33 Million in Smith & Nephew SNATS, Inc. $SNN
August 25 at 3:21 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-bank-of-new-york-mellon-corp-invests-8933-million-in-smith-nephew-snats-inc-snn-2026-08-25/
Smith & Nephew SNATS (NYSE:SNN) Rating Increased to Buy at Wall Street Zen
August 24, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30979079
Wall Street Zen Upgrades Smith & Nephew SNATS (NYSE:SNN) to Buy
August 24, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/wall-street-zen-upgrades-smith-nephew-snats-nysesnn-to-buy-2026-08-24/
Quantbot Technologies LP Invests $6.34 Million in Smith & Nephew SNATS, Inc. $SNN
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantbot-technologies-lp-invests-634-million-in-smith-nephew-snats-inc-snn-2026-08-23/
Heartland Advisors Inc. Makes New Investment in Smith & Nephew SNATS, Inc. $SNN
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-heartland-advisors-inc-makes-new-investment-in-smith-nephew-snats-inc-snn-2026-08-23/
Deutsche Bank AG Buys New Position in Smith & Nephew SNATS, Inc. $SNN
August 22, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-deutsche-bank-ag-buys-new-position-in-smith-nephew-snats-inc-snn-2026-08-22/
Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN) and Olema Pharmaceuticals (OLMA)
August 22, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/OLMA/pressreleases/3967714/analysts-offer-insights-on-healthcare-companies-smith-nephew-snats-snn-and-olema-pharmaceuticals-olma/
Mitsubishi UFJ Asset Management Co. Ltd. Makes New $13.81 Million Investment in Smith & Nephew SNATS, Inc. $SNN
August 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-mitsubishi-ufj-asset-management-co-ltd-makes-new-1381-million-investment-in-smith-nephew-snats-inc-snn-2026-08-21/
SNN Advances Surgical Robotics Through Imperial College Partnership
August 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2977175/snn-advances-surgical-robotics-through-imperial-college-partnership?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2977175
Smith & Nephew SNATS (NYSE:SNN) Shares Gap Down - Should You Sell?
August 19, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/smith-nephew-snats-nysesnn-shares-gap-down-should-you-sell-2026-08-19/
Smith & Nephew shares slip on CFO's departure
August 19, 2026  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1097256?snapi
Smith & Nephew drops 3.5% as finance chief quits
August 19, 2026  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1097257?snapi
Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand for Hip Surgery
August 18, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2976488/smith-nephew-launches-flow-flextend-coblation-wand-for-hip-surgery?cid=cs-stocknewsapi-ft-analyst_blog|company_news_medical_sector-2976488

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
SpaceX logo beside a rocket on a launch pad at sunset, with a colorful sky in the background.
SpaceX’s First Earnings Report Could Decide Whether Shorts or Bulls Have Control
By Jeffrey Neal Johnson | August 3, 2026
Microsoft logo displayed on a wall-mounted plaque in a modern office lobby with glass partitions.
Microsoft Just Flipped the AI Spending Narrative Overnight
By Chris Markoch | July 30, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
Amazon-branded package carried by a delivery drone inside a warehouse, highlighting Amazon logistics and tech momentum.
Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
By Sam Quirke | July 31, 2026
Data center aisle with server racks, blue lighting, and coolant supply and return pipes with gauges.
3 Stocks That Prove the AI Trade Isn't Over, It Moved
By Bridget Bennett | August 5, 2026
Baxter International stock logo

Baxter International NYSE:BAX

$25.97 -0.53 (-1.99%)
Closing price 08/27/2026 03:59 PM Eastern
Extended Trading
$26.19 +0.21 (+0.82%)
As of 07:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

iRhythm Technologies stock logo

iRhythm Technologies NASDAQ:IRTC

$116.33 -2.82 (-2.37%)
Closing price 08/27/2026 04:00 PM Eastern
Extended Trading
$116.38 +0.05 (+0.04%)
As of 07:27 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Penumbra stock logo

Penumbra NYSE:PEN

$321.51 -1.54 (-0.48%)
Closing price 08/27/2026 03:59 PM Eastern
Extended Trading
$320.26 -1.25 (-0.39%)
As of 07:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Smith & Nephew SNATS stock logo

Smith & Nephew SNATS NYSE:SNN

$29.14 -0.17 (-0.56%)
Closing price 08/27/2026 03:59 PM Eastern
Extended Trading
$29.00 -0.14 (-0.47%)
As of 07:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas